Central Nervous System Agents
-
Subject Areas on Research
- A guide to the safety of CNS-active agents during breastfeeding.
- A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia.
- Adverse drug events in high risk older outpatients.
- Authors' Reply to Courtney Suggs and Colleagues' Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs".
- Catechol-O-methyltransferase inhibition alters pain and anxiety-related volitional behaviors through activation of β-adrenergic receptors in the rat.
- Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.
- Drug-drug interactions in older adults: which ones matter?
- Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
- Ghrelin receptor antagonism of hyperlocomotion in cocaine-sensitized mice requires βarrestin-2.
- Impact of restarting home neuropsychiatric medications on sedation outcomes in medical intensive care unit patients.
- Influence of common drugs and related factors on stroke outcome.
- Is medication use by community-dwelling elderly people influenced by cognitive function?
- Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs.
- Neuropharmacology of TBI-induced plasticity.
- Occipital Headache in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).
- Perioperative management of drug therapy, clinical considerations.
- Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care.
- Psychotropic medication use in children with autism in the Kentucky Medicaid population.
- Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats.
- Stimulant-related reductions of growth rates in the PATS.